ENANTA PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $438.8M
Liabilities Breakdown FY2021
Total Liabilities: $39.4M
Asset Breakdown
Total Assets: $438.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.2M | 13.0% |
| Accounts Receivable | $23.6M | 5.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.9M | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $352.1M | 80.2% |
Liabilities Breakdown
Total Liabilities: $39.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.5M | 24.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $29.8M | 75.8% |